Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Planning Grant: Orphan GPCR ligands from Ethnobotanical Sources as Novel Drugs for Mental Disorders

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Global Brain Disorders Research

Project Information in NIH RePORTER

Orphan GPCR ligands from Ethnobotanical Sources as Novel Drugs for Mental Disorders

Principal Institution

Universidad Peruana Cayetano Heredia

Principal Investigator(s) (PI)

Vaisberg, Abraham

Project Contact Information

Email: abraham.vaisberg@upch.pe

Year(s) Awarded

2018-2023

Country

Peru

NIH Partners

NIMH

Project Description

Mental disorders are multidimensional, genetically complex and severely disabling diseases, with a strong need for pharmacotherapies with better adherence, long-term outcome and patient functionality. However, current advancements in the field have not yet led to the introduction of truly novel pharmacological approaches to treatment. This project aims to take advantage of traditional medicine knowledge to direct the discovery of novel therapeutics for mental disorders that will eventually help to unravel yet poorly understood biological processes behind the occurrence of these diseases.

Related World Regions / Countries

Western Hemisphere